Showing 1 - 9 results of 9 for search 'Konieczny, A', query time: 0.02s
Refine Results
-
1
The final results of the interferon beta-1b 16-year long-term follow-up study by Ebers, G, Traboulsee, A, Langdon, D, Reder, A, Miltenburger, C, Wolf, C, Konieczny, A
Published 2006Conference item -
2
The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes by Reder, A, Ebers, G, Goodin, D, Li, D, Traboulsee, A, Beckman, K, Konieczny, A
Published 2008Conference item -
3
Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS. by Reder, A, Ebers, G, Traboulsee, A, Li, D, Langdon, D, Goodin, D, Bogumil, T, Beckmann, K, Konieczny, A
Published 2010Journal article -
4
EDSS and MRI burden of disease predict cognitive status at 16 years: data from the long term follow-up study by Langdon, D, Reder, A, Ebers, G, Goodin, D, Traboulsee, A, Li, D, Beckmann, K, Konieczny, A, Grp, 1
Published 2007Conference item -
5
-
6
Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial. by Ebers, G, Traboulsee, A, Li, D, Langdon, D, Reder, A, Goodin, D, Bogumil, T, Beckmann, K, Wolf, C, Konieczny, A
Published 2010Journal article -
7
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis by Goodin, D, Traboulsee, A, Knappertz, V, Reder, A, Li, D, Langdon, D, Wolf, C, Beckmann, K, Konieczny, A, Ebers, G
Published 2012Journal article -
8
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis. by Goodin, D, Traboulsee, A, Knappertz, V, Reder, A, Li, D, Langdon, D, Wolf, C, Beckmann, K, Konieczny, A, Ebers, G
Published 2012Journal article -
9
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis by Goodin, D, Traboulsee, A, Knappertz, V, Knappertz, V, Knappertz, V, Reder, A, Li, D, Langdon, D, Wolf, C, Beckmann, K, Konieczny, A, Ebers, G
Published 2012Journal article